Cannabis Use Linked to 29% Higher Heart Attack Risk and Double the Cardiovascular Death Risk

A meta-analysis of 24 studies found cannabis use associated with a 29% increased risk of acute coronary syndrome, 20% increased stroke risk, and 110% increased cardiovascular death risk.

Storck, Wilhelm et al.·Heart (British Cardiac Society)·2025·Moderate EvidenceMeta-Analysis
RTHC-07731Meta AnalysisModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Meta-Analysis
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Risk ratios for cannabis users: ACS 1.29 (95% CI 1.05-1.59), stroke 1.20 (1.13-1.26), cardiovascular death 2.10 (1.29-3.42). No significant association for composite ACS+stroke. Sensitivity analysis restricted to cohort studies yielded comparable results (RR 1.32, 1.01-1.73). 24 studies included: 17 cross-sectional, 6 cohort, 1 case-control.

Key Numbers

24 studies from 3,012 screened. 17 cross-sectional, 6 cohort, 1 case-control. ACS RR: 1.29. Stroke RR: 1.20. CV death RR: 2.10. Cohort-only analysis: RR 1.32 for ACS.

How They Did This

Systematic review and meta-analysis (PROSPERO: CRD42023401401) of pharmacoepidemiological studies published January 2016-January 2023. Searched PubMed, Web of Science, Scopus. Quality assessed with ROBINS-E tool. DerSimonian-Laird random effects meta-analysis with inverse variance weighting.

Why This Research Matters

This is one of the most comprehensive quantitative assessments of cannabis cardiovascular risk. The elevated cardiovascular death risk (2.1x) is particularly concerning given increasing cannabis use and the often-overlooked cardiac effects.

The Bigger Picture

While most cannabis safety discussions focus on mental health or respiratory effects, this meta-analysis provides pooled evidence that cardiovascular risks are real and quantifiable. The magnitude of the cardiovascular death association is notable.

What This Study Doesn't Tell Us

Most included studies were cross-sectional, limiting causal inference. Exposure measurement varied across studies. Potential residual confounding from co-use of other substances. Heterogeneity in study populations and designs.

Questions This Raises

  • ?Does the cardiovascular risk vary by cannabis product type or consumption method?
  • ?Are certain populations (age groups, pre-existing conditions) at higher cardiovascular risk from cannabis?

Trust & Context

Key Stat:
Evidence Grade:
Systematic review and meta-analysis with registered protocol and sensitivity analyses, though predominantly cross-sectional source studies limit to moderate.
Study Age:
Studies published 2016-2023, search through September 2023.
Original Title:
Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis.
Published In:
Heart (British Cardiac Society), 111(22), 1047-1056 (2025)
Database ID:
RTHC-07731

Evidence Hierarchy

Meta-Analysis / Systematic ReviewCombines many studies into one answer
This study
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Combines results from multiple studies to find an overall pattern.

What do these levels mean? →

Frequently Asked Questions

Does cannabis increase heart attack risk?

This meta-analysis found a 29% increased risk of acute coronary syndrome (which includes heart attacks) among cannabis users across 24 studies.

How serious is the cardiovascular risk from cannabis?

The most concerning finding was a 2.1-fold increased risk of cardiovascular death. Stroke risk was elevated by 20%. These associations persisted when analysis was restricted to higher-quality cohort studies.

Read More on RethinkTHC

Cite This Study

RTHC-07731·https://rethinkthc.com/research/RTHC-07731

APA

Storck, Wilhelm; Elbaz, Meyer; Vindis, Cécile; Déguilhem, Amélia; Lapeyre-Mestre, Maryse; Jouanjus, Emilie. (2025). Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis.. Heart (British Cardiac Society), 111(22), 1047-1056. https://doi.org/10.1136/heartjnl-2024-325429

MLA

Storck, Wilhelm, et al. "Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis.." Heart (British Cardiac Society), 2025. https://doi.org/10.1136/heartjnl-2024-325429

RethinkTHC

RethinkTHC Research Database. "Cardiovascular risk associated with the use of cannabis and ..." RTHC-07731. Retrieved from https://rethinkthc.com/research/storck-2025-cardiovascular-risk-associated-with

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.